Company news
CanadaBis Capital, Inc. news in 2024
CanadaBis Capital, Inc.'s news releases, calls and decks from 2024, newest first.
CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Record Revenue Q1 F2025 Resulting in $9.6M Gross with $321,569 in NET Earnings and an Adjusted EBITDA of $675,892
December 31, 2024
CanadaBis Capital Reports Positive Net Income and Strong Financial Performance for Fiscal Year End 2024
November 28, 2024
CanadaBis Capital reports strong financial results for Q3 2024
June 26, 2024
Canadabis Capital Expands into European Market with EU-GMP Partners
May 7, 2024
Canadabis Capital Unveils New 60%+ Double-Infused Pre-Roll under Dab Bods Brand, Setting New Standard for THC Potency in Canadian Market
April 23, 2024
CanadaBis Capital, with sub stigma grow, announces fiscal Q2 2024 results highlighted by continued positive adjusted EBITDA(1) and net income
April 1, 2024
CanadaBis Capital confirms no material change
April 1, 2024
CanadaBis Capital, with sub stigma grow, announces fiscal Q1 2024 results highlighted by year-over-year growth in revenue, adjusted EBITDA¹ and net income
January 2, 2024